• bluebird bio, Inc. (NASDAQ:BLUE) Given Consensus Rating of "Hold" by Analysts

    来源: Buzz FX / 12 1月 2025 03:21:16   America/Chicago


    bluebird bio, Inc. (NASDAQ:BLUE) Given Consensus Rating of "Hold" by Analysts Written by MarketBeat January 12, 2025 Share Link copied to clipboard. Shares of bluebird bio, Inc. ( NASDAQ:BLUE - Get Free Report ) have been assigned a consens
    Read more...
分享